What are the Policy Implications of the Evidence on Cannabis and Psychosis?
The Canadian Journal of Psychiatry August 1, 2006 DOI: 10.1177/070674370605100904 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Cannabis |
| Key points | Argues that observational evidence and biological plausibility indicate cannabis is a contributory cause of psychosis, at least as strong as evidence for alcohol and amphetamine. Proposes discouraging cannabis use among adolescents and young adults on public health grounds, while acknowledging uncertainty about optimal strategies. |
Abstract
Objective: To explore the implications for mental health services, for health education about the risks of cannabis use, and for public policy toward cannabis use of observational evidence that cannabis use is a contributory cause of psychosis.
Method: Using comparative analyses of similar evidence for the harmful effects of alcohol, tobacco, and amphetamine use, we considered the relation between observational evidence and action on cannabis. We examined arguments on the grounds of public health prudence for discouraging cannabis use by young individuals. With the assumption that the relation may be causal, we considered recommendations for policy in mental health services, health education, and public policy toward cannabis.
Results: The observational evidence and biological plausibility of the hypothesis that cannabis is a contributory cause of psychosis is at least as strong as evidence for causal relations between heavy alcohol and amphetamine use and psychosis. On public health grounds, there is a good case for discouraging cannabis use among adolescents and young adults. It remains uncertain how best to discourage use and at whom campaigns to reduce cannabis use should be targeted.
Conclusions: We should discourage young adults seeking treatment in mental health services from using cannabis and inform them of the probable mental health risks of cannabis use, especially of early and frequent use. We must exercise caution in liberalizing cannabis laws in ways that may increase young individuals' access to cannabis, decrease their age of first use, or increase their frequency of cannabis use. We should consider the feasibility of reducing the availability of high-potency cannabis products.
Comparable studies
Other theoretical and historical papers on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Delta-8, Delta-10, HHC, THC-O, THCP, and THCV: What Should We Call These Products? | 2023 | Theoretical or philosophical paper | |
| Model Psychoses Induced by LSD-25 in Normals | 1956 | Historical analysis | |
| Is there a specific ‘cannabis psychosis’? | 2004 | Theoretical or philosophical paper | |
| Peak-experience and the entheogenic use of cannabis in world religions | 2021 | Theoretical or philosophical paper | |
| Out of Harm's Way?: Illicit Drug Use, Medicalization and the Law | 2003 | Theoretical or philosophical paper |
Citations in the library
Cited by 5
- Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome Psychological Medicine December 1, 2012
- Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies. The International journal on drug policy 2010
- EEG of chronic marijuana users during abstinence: relationship to years of marijuana use, cerebral blood flow and thyroid function. Clinical Neurophysiology February 2008
- Cannabis use and the risk of developing a psychotic disorder. World Psychiatry 2008
- The toxicology of cannabis and cannabis prohibition. Chemistry & Biodiversity August 2007
Cites 11
- Causal association between cannabis and psychosis: examination of the evidence The British Journal of Psychiatry January 30, 2004
- Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases The British Journal of Psychiatry November 30, 2005
- Cannabis use and psychotic disorders: an update Drug and Alcohol Review November 30, 2004
- New Perspectives in the Studies on Endocannabinoid and Cannabis: Cannabinoid Receptors and Schizophrenia Journal of Pharmacological Sciences 2004
- Cannabinoid ‘model’ psychosis, dopamine–cannabinoid interactions and implications for schizophrenia Cambridge University Press eBooks May 27, 2004
and 6 more in the library